Skip to main content

REINSURANCE GROUP OF AMERICA INC

For the period ended Dec 31, 2025. Filed Feb 20, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 20, 2026

RGA$274.06+2.7%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Europe, Middle East and Africa Operations

EMEA operations consist of two major segments: Traditional and Financial Solutions. The Traditional segment primarily provides reinsurance through yearly renewable term and coinsurance agreements on a variety of life, health and critical illness products. Reinsurance agreements may be facultative or automatic agreements covering primarily individual risks and, in some markets, group risks. The Financial Solutions segment consists of reinsurance and other transactions associated with longevity closed blocks, payout annuities, capital management solutions and financial reinsurance.

The following table sets forth the EMEA operating results for the periods indicated (dollars in millions). See additional information in the Traditional and Financial Solutions sections.

For the year ended December 31,
202520242025 vs 2024
Total segment revenues3,8443,138706
Total adjusted benefits and expenses3,4812,763718
Adjusted operating income before income taxes$363$375$(12)

The decrease in adjusted operating income before income taxes was primarily due to the unfavorable impact of the Company’s annual assumptions update which resulted in a future policy benefits remeasurement loss of $185 million.

The following table sets forth the EMEA Traditional segment operating results for the periods indicated (dollars in millions):

For the year ended December 31,
2025 · 2024 · 2025 vs 2024
Segment revenues
Net premiums$2,258$2,002$256
Net investment income12911217
Investment related gains (losses), net———
Other revenues1011(1)
Total segment revenues2,3972,125272
Adjusted benefits and expenses
Adjusted claims and other policy benefits2,0741,805269
Future policy benefits remeasurement (gains) losses20448156
Adjusted interest credited———
Policy acquisition costs and other insurance expenses1111092
Other operating expenses114133(19)
Total adjusted benefits and expenses2,5032,095408
Adjusted operating income before income taxes$(106)$30$(136)
Key metrics
Life reinsurance in force$1,113.1 billion$970.4 billion
Future policy benefits remeasurement (gains) losses
Effect of changes in cash flow assumptions$222$40
Effect of actual variances from expected experience$(18)$8
Loss ratio (1)101%93%
Policy acquisition costs and other insurance expenses as a percentage of net premiums5%5%
Other operating expenses as a percentage of net premiums5%7%

The decrease in adjusted operating income before income taxes in 2025 was primarily due to the unfavorable impacts of the Company’s annual assumptions review discussed below.

The increase in net premiums was due to increases in business volume on new and existing treaties.

The segment added new life business production, measured by face amount of life reinsurance in force, of $171.8 billion and $119.5 billion during 2025 and 2024, respectively.

The increase in the loss ratio was primarily due to unfavorable assumption updates attributable to updated long-term mortality assumptions in the U.K.

During the third quarter of 2025, the Company completed its annual assumptions review resulting in a net unfavorable assumption update totaling $222 million, primarily due to updated mortality assumptions in the U.K. to reflect deterioration in mortality improvements and ongoing challenges within the healthcare system. The 2024 annual assumptions update resulted in a loss of $5 million in the third quarter of 2024. See Note 5 – “Future Policy Benefits” for additional information.

The following table sets forth the EMEA Financial Solutions segment operating results for the periods indicated (dollars in millions):

For the year ended December 31,
202520242025 vs 2024
Segment revenues
Net premiums$959$660$299
Net investment income435319116
Investment related gains (losses), net2—2
Other revenues513417
Total segment revenues1,4471,013434
Adjusted benefits and expenses
Adjusted claims and other policy benefits893562331
Future policy benefits remeasurement (gains) losses(37)3(40)
Adjusted interest credited2630(4)
Policy acquisition costs and other insurance expenses981
Other operating expenses876522
Total adjusted benefits and expenses978668310
Adjusted operating income before income taxes$469$345$124
Key metrics
Future policy benefits remeasurement (gains) losses
Effect of changes in cash flow assumptions$(24)$3
Effect of actual variances from expected experience$(13)$—

The increase in adjusted operating income before income taxes in 2025 was primarily due to increases in net investment income, growth in closed blocks longevity business and increases in future policy benefits remeasurement gains as a result of the Company’s annual assumptions update discussed below.

The increase in net premiums was primarily due to increased volumes on new and existing treaties.

The increase in net investment income was primarily due to an increase in invested assets supporting the segment.

The increase in adjusted claims and other policy benefits was the result of increased volumes of closed block longevity business and asset-intensive transactions.

During the third quarter of 2025 and 2024, the Company completed its annual assumptions review resulting in a net favorable assumption update totaling $24 million in the third quarter of 2025, primarily due to updated longevity based mortality in the U.K. The 2024 annual assumptions update resulted in a loss of $3 million in the third quarter of 2024. See Note 5 – “Future Policy Benefits” for more information.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.